Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EDIT-401 in Adults With Heterozygous Familial Hypercholesterolemia
NCT07894887Phase 2Not yet recruiting
- Sponsor
- Editas Medicine
- Start
- Nov 2026
- Primary completion
- Jun 2029
- Countries
- 1
01
Overview
A Phase 2 trial of edit-401 in heterozygous familial hypercholesterolemia (HeFH), sponsored by Editas Medicine. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
edit-401
03
Conditions
heterozygous familial hypercholesterolemia (HeFH)
Beyond the preview
Go deeper on NCT07894887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07894887.